IP Library Granted Patent US 8,859,766
Granted Patent B2
US 8,859,766 · App. 14/133,045 · Granted Oct 14, 2014

Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid

Inventors: Shin Chung (Yongin-si, KR); Heui-Yeon Kim (Incheon, KR); Hyun-Jin Park (Anyang-si, KR); Mi-Ran Kim (Anseong-si, KR); Jong-Ook Lee (Seoul, KR)
Assignee: OliPass Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,859,766
App. No.
14/133,045
Granted
Oct 14, 2014
Kind
B2
Abstract

The present invention provides a novel class of peptide nucleic acid derivatives, which show good cell penetration and strong binding affinity for nucleic acid.

Claims (23)

1. A compound of Formula VII:

wherein,

R 8 is hydrido, N-succinyl, or substituted or non-substituted alkyl radical;

P 1 is selected from hydrido, t-butoxycarbonyl, (9H-fluoren-9-yl)methoxy-carbonyl, substituted or non-substituted benzyloxycarbonyl, and substituted or non-substituted arylsulfonyl radical;

P 2 is selected from hydrido, t-butoxycarbonyl, (9H-fluoren-9-yl)methoxy-carbonyl, substituted or non-substituted benzyloxycarbonyl, substituted alkyloxycarbonyl, substituted or non-substituted alkyl, amidinyl, 1,3-bis(t-butoxy-carbonyl)amidinyl, 1,3-bis-(benzyl-oxycarbonyl)amidinyl radical;

P 3 is selected from hydrido, t-butoxycarbonyl, (9H-fluoren-9-yl)methoxy-carbonyl, and substituted or non-substituted benzyloxycarbonyl radical;

P 4 is selected from hydrido, and t-butoxycarbonyl radical; and,

L 2 is a linker represented by Formula V:

wherein,

Q 1 and Q m are substituted or non-substituted methylene radical, and Q m is directly linked to the amino radical;

Q 2 , Q 3 , . . . , and Q m-1 are independently selected from substituted or non-substituted methylene, oxygen, sulfur, and substituted or non-substituted amino radical; and,

m is an integer from 2 to 15.

2. A compound of Formula X:

wherein,

R 11 is hydroxy, substituted or non-substituted alkyloxy, or substituted or non-substituted amino radical;

P 2 is selected from hydrido, t-butoxycarbonyl, (9H-fluoren-9-yl)methoxy-carbonyl, substituted or non-substituted benzyloxycarbonyl, substituted alkyloxycarbonyl, substituted or non-substituted alkyl, amidinyl, 1,3-bis(t-butoxy-carbonyl)amidinyl, 1,3-bis-(benzyl-oxycarbonyl)amidinyl radical;

P 3 is selected from hydrido, t-butoxycarbonyl, (9H-fluoren-9-yl)methoxy-carbonyl, and substituted or non-substituted benzyloxycarbonyl radical;

P 4 is selected from hydrido, and t-butoxycarbonyl radical; and,

L 2 is a linker represented by Formula V:

wherein,

Q 1 and Q m are substituted or non-substituted methylene radical, and Q m is directly linked to the amino radical;

Q 2 , Q 3 , . . . , and Q m-1 are independently selected from substituted or non-substituted methylene, oxygen, sulfur, and substituted or non-substituted amino radical; and,

m is an integer from 2 to 15.

Assignments (2)
CHANGE OF NAME Recorded Feb 3, 2014
From: CTI BIO
To: OLIPASS CORPORATION
Reel/Frame 032152/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2013
From: CHUNG, SHIN; LEE, JONG-OOK; KIM, HEUI-YEON; PARK, HYUN-JIN; KIM, MI-RAN
To: CTI BIO
Reel/Frame 031820/0112 →
Priority Claims (2)
KR 10-2008-0023658 · Mar 14, 2008 · national
KR 10-2008-0111459 · Nov 11, 2008 · national
Continuity (2)
Division 12922322
Related Publication 20140155605A1 · Jun 5, 2014